Citigroup downgraded shares of Integra LifeSciences (NASDAQ:IART – Get Rating) from a neutral rating to a sell rating in a research note issued to investors on Tuesday, The Fly reports. Citigroup currently has $39.00 price objective on the life sciences company’s stock, down from their previous price objective of $59.00. Several other brokerages also recently […]

Integra Lifesciences Michaelj Mcbreen Lisa Evoli Metlife Investment Management Yousif Capital Management Raymond James Associates

Source: themarketsdaily.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Integra LifeSciences Holdings Co. (NASDAQ:IART) Position Decreased by Dimensional Fund Advisors LP

May 26, 2023

Dimensional Fund Advisors LP decreased its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,203,527 shares of the life sciences company’s stock after selling 71,407 shares […]

United States Ivanovskaya Oblast Lisa Evoli Michaelj Mcbreen Integra Lifesciences Integra Lifesciences Holdings Co

Source: defenseworld.net

Integra LifeSciences' (IART) Downgrade Rating Reaffirmed at 22nd Century Group

May 26, 2023

22nd Century Group reaffirmed their downgrade rating on shares of Integra LifeSciences (NASDAQ:IART – Get Rating) in a report published on Tuesday morning, Benzinga reports. Several other equities research analysts have also recently commented on IART. Citigroup cut Integra LifeSciences from a neutral rating to a sell rating and lowered their price target for the […]

Integra Lifesciences Lisa Evoli Michaelj Mcbreen Jpmorgan Chase Co Proficio Capital Partners Third Bancorp

Source: wkrb13.com

IART INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Inquire About Securities Class Action Investigation

May 26, 2023

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

United States New York Phillip Kim Laurence Rosen Drug Administration Rosen Law Firm

Source: prnewswire.com

22nd Century Group Reiterates "Downgrade" Rating for Integra LifeSciences (NASDAQ:IART)

May 26, 2023

Integra LifeSciences (NASDAQ:IART – Get Rating)‘s stock had its “downgrade” rating reissued by 22nd Century Group in a research report issued to clients and investors on Tuesday, Benzinga reports. Other equities research analysts also recently issued reports about the company. StockNews.com began coverage on Integra LifeSciences in a research report on Thursday, May 18th. They […]

Lisa Evoli Michaelj Mcbreen Integra Lifesciences Metlife Investment Management Century Group Raymond James Associates

Source: theenterpriseleader.com